Navigating the landscape of terminal care and access to medications like Pentobarbital in New South Wales, the state, requires a careful grasp of the complex legal structure. Currently, Pentobarbital does not have a approved place on the Pharmaceutical Benefits Scheme (this program) and is therefore not commonly prescribed by healthcare professiona